Browsing by Subject "DNA Modification Methylases"
Now showing items 1-2 of 2
-
MGMT immunohistochemistry in pituitary tumors: controversies with clinical implications
(2019)Introduction: Temozolomide (TMZ) is currently considered as a rational therapeutic option for patients with progressively aggressive pituitary adenomas and carcinomas not responding to conventional therapies. Administration ...